[Federal Register Volume 60, Number 21 (Wednesday, February 1, 1995)]
[Notices]
[Page 6141]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-2374]
[[Page 6141]]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Meetings
Pursuant to Section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the National
Institute on Drug Abuse (NIDA) advisory committee meetings.
These meetings will be open to the public as indicated below with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the contact person in
advance of the meeting.
Ms. Camilla L. Holland, NIDA Committee Management Officer, National
Institutes of Health, Parklawn Building, Room 10-42, 5600 Fishers Lane,
Rockville, MD 20857, (301) 443-2755, will provide summaries of the
meetings and rosters of committee members upon request. Substantive
program information may be obtained from the contacts listed below.
Committee Name: National Advisory Council on Drug Abuse
Meeting Date: February 7-8, 1995
Place:
February 7, National Institutes of Health, Building 31, Conference
Room 10, 9000 Rockville Pike, Bethesda, MD 20892
February 8, Parklawn Building, Conference, Room G, 5600 Fishers
Lane, Rockville, MD 20857
Open: February 7, 1995, 9 a.m.-5 p.m.
Agenda: Administrative, legislative, and program development reports
Closed: February 8, 1995, 9 a.m. to adjournment
Agenda: Review and evaluation of grant applications
Contact: Eleanor C. Friedenberg, Executive Secretary, Parklawn
Building, Room 10-42, 5600 Fishers Lane, Rockville, MD 20857, Telephone
(301) 443-2755
Committee Name: Drug Abuse Biomedical Research Review Committee
Meeting Date: February 13, 1995
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, Bethesda, MD
20814
Open: February 13, 8:30 a.m. to 9:30 a.m.
Agenda: Presentation by the Director, NIDA
Contact: Gamil Debbas, Ph.D., Scientific Review Administrator, Parklawn
Building, Room 10-42, 5600 Fishers Lane, Rockville, MD 20857, Telephone
(301) 443-2620
Committee Name: Biochemistry Research Subcommittee, Drug Abuse
Biomedical Research Review Committee
Meeting Date: February 13-15, 1995
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, Bethesda, MD
20814
Closed: 12 Noon
Agenda: Review and evaluation of grant applications
Contact: Rita Liu, Ph.D., Scientific Review Administrator, Parklawn
Building, Room 10-42, 5600 Fishers Lane, Rockville, MD 20857, Telephone
(301) 443-2620
Committee Name: Pharmacology I Research Subcommittee, Drug Abuse
Biomedical Research Review Committee
Meeting Date: February 13-15, 1995
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, Bethesda, MD
20814
Closed: 9:30 a.m.
Agenda: Review and evaluation of grant applications
Contact: Syed Husain, Ph.D., Scientific Review Administrator, Parklawn
Building, Room 10-42, 5600 Fishers Lane, Rockville, MD 20857, Telephone
(301) 443-2620
Committee name: Pharmacology II Research Subcommittee, Drug Abuse
Biomedical Research Review Committee
Meeting Date: February 13-15, 1995
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, Bethesda, MD
20814
Closed: 9:30 a.m.
Agenda: Review and evaluation of grant applications
Contact: Gamil Debbas, Ph.D., Scientific Review Administrator, Parklawn
Building, Room 10-42, 5600 Fishers Lane, Rockville, MD 20857, Telephone
(301) 443-2620.
Committee name: Drug Abuse Epidemiology and Prevention Research Review
Committee
Meeting Date: February 14-15, 1995
Place: Ramada Inn, Rockville, 1775 Rockville Pike, Rockville, MD 20852
Open: February 14, 8:30 a.m. to 9:30 a.m.
Agenda: Presentation by the Director, NIDA
Closed: 9:30 a.m.
Agenda: Review and evaluation of grant applications
Contact: Raquel Crider, Ph.D., Scientific Review Administrator,
Parklawn Building, Room 10-22, 5600 Fishers Lane, Rockville, MD 20857,
Telephone (301) 443-9042.
These meetings will be closed in accordance with provisions set
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. Applications
and the discussions could reveal confidential trade secrets or
commercial property such as patentable material and personal
information concerning individuals associated with the applications,
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
This notice is being published less than fifteen days prior to the
meeting due to the urgent need to meet timing limitations imposed by
the grant review cycle.
(Catalog of Federal Domestic Assistance Program Numbers: 93.277,
Drug Abuse Research Scientist Development and Research Scientist
Awards; 93.278, Drug Abuse National Research Service Awards for
Research Training; 93.279, Drug Abuse Research Programs)
Dated: January 25, 1995.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 95-2374 Filed 1-31-95; 8:45 am]
BILLING CODE 4140-01-M
